Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient

References

• Lipinski C. Poor aqueous solubility—an industry wide problem in drug discovery. Am Pharma Rev. 2002;5:82–85.
   Google Scholar
• Mohsin K. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion. AAPS Pharmsci tech. 2012;13:637–646.
   PubMed Web of Science ®Google Scholar
• Tang B, Cheng G, Gu J-C, et al. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today. 2008;13:606–612. 2008/07/01/
   PubMed Web of Science ®Google Scholar
• Quan G, Niu B, Singh V, et al. Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement. Ijn. 2017;12:8801.
   Web of Science ®Google Scholar
• Bevernage J, Forier T, Brouwers J, et al. Excipient-mediated supersaturation stabilization in human intestinal fluids. Mol Pharmaceutics. 2011;8:564–570.
   PubMed Web of Science ®Google Scholar
• Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006;3:97–110.
   PubMedGoogle Scholar
• Warren DB, Benameur H, Porter CJ, et al. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Targeting. 2010;18:704–731.
   PubMed Web of Science ®Google Scholar
• Warren DB, Bergström CAS, Benameur H, et al. Evaluation of the structural determinants of polymeric precipitation inhibitors using solvent shift methods and principle component analysis. Mol Pharmaceutics. 2013;10:2823–2848.
   PubMed Web of Science ®Google Scholar
• Thomas N, Holm R, Garmer M, et al. Supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. Aaps J. 2013;15:219–227.
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mellaerts R, Mols R, et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur J Pharm Sci. 2010;41:623–630.
   PubMed Web of Science ®Google Scholar
• Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98:2549–2572.
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274:65–73.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Siddiqui A, Ali H, et al. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). Int J Pharm. 2009;366:44–52. 2009/01/21/
   PubMed Web of Science ®Google Scholar
• Gumaste SG, Freire BO, Serajuddin AT. Development of solid SEDDS, VI: effect of precoating of Neusilin® US2 with PVP on drug release from adsorbed self-emulsifying lipid-based formulations. Eur J Pharma Sci. 2017;110:124–133.
   PubMed Web of Science ®Google Scholar
• Mahajan H, Shaikh T, Baviskar D, et al. Design and development of solid self-micro-emulsifying drug delivery system (SMEDDS) of fenofibrate. Int J Pharma Pharmaceutic Sci. 2011;3:163–166.
   Google Scholar
• Shah AV, Serajuddin AT. Development of solid self-emulsifying drug delivery system (SEDDS) I: use of poloxamer 188 as both solidifying and emulsifying agent for lipids. Pharm Res. 2012;29:2817–2832.
   PubMed Web of Science ®Google Scholar
• Shazly G, Mohsin K. Dissolution improvement of solid self-emulsifying drug delivery systems of fenofi brate using an inorganic high surface adsorption material. Acta Pharmaceutica. 2015;65:29–42.
   PubMed Web of Science ®Google Scholar
• Devraj R, Williams HD, Warren DB, et al. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine. Eur J Pharm Sci. 2013;49:748–760.
   PubMed Web of Science ®Google Scholar
• Patel AR, Vavia PR. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. Aaps J. 2007;9:E344–E352.
   PubMed Web of Science ®Google Scholar
• Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–182.
   PubMed Web of Science ®Google Scholar
• Mohsin K, Rayan Alamri AA, Raish M, et al. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. Int J Nanomed. 2016;11:2829.
   PubMed Web of Science ®Google Scholar
• Beg S, Sandhu PS, Batra RS, et al. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv. 2015;22:765–784.
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625–637.
   PubMed Web of Science ®Google Scholar
• Williams HD, Van Speybroeck M, Augustijns P, et al. Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: Effect of drug type and formulation composition on in vitro pharmaceutical performance. J Pharm Sci. 2014;103:1734–1746.
   PubMed Web of Science ®Google Scholar
• Gurram A, Deshpande PB, Kar SS, et al. Role of components in the formation of self-microemulsifying drug delivery systems. Indian J Pharm Sci. 2015;77:249.
   PubMed Web of Science ®Google Scholar
• Cole ET, Cadé D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60:747–756.
   PubMed Web of Science ®Google Scholar
• Pekson R, Poltoratsky V, Gorasiya S, et al. N, N-Dimethylacetamide significantly attenuates LPS-and TNFα-Induced proinflammatory responses via inhibition of the nuclear factor kappa B pathway. Mol Med. 2016;22:747.
   PubMed Web of Science ®Google Scholar
• Sundaram S, Ashby CR, Pekson R, et al. N,N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth. Am J Pathol. 2013;183:422–430.
   PubMed Web of Science ®Google Scholar
• Gumaste SG, Serajuddin ATM. Development of solid SEDDS, VII: effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations. Eur J Pharm Sci. 2017;110:134–147.
   PubMed Web of Science ®Google Scholar
• Patil P, Paradkar A. Porous polystyrene beads as carriers for self-emulsifying system containing loratadine. AAPS PharmSciTech. 2006;7:E199–E205.
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Williams HD, Nguyen T-H, et al. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier. Mol Pharmaceutics. 2012;9:2750–2760.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Tseng Y-C, Goldman D, et al. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharma Res. 2002;19:1663–1672.
   Web of Science ®Google Scholar
• Chavan RB, Modi SR, Bansal AK. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib. Int J Pharm. 2015;495:374–384. /11/10/
   PubMed Web of Science ®Google Scholar
• Limnell T, Riikonen J, Salonen J, et al. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles. Int J Pharma. 2007;343:141–147. /10/01/
   PubMed Web of Science ®Google Scholar
• Cha K-H, Cho K-J, Kim M-S, et al. Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide. Int J Nanomed. 2012;7:5565.
   PubMed Web of Science ®Google Scholar
• Kim GG, Poudel BK, Marasini N, et al. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems. Drug Dev Ind Pharm. 2013;39:1431–1438.
   PubMed Web of Science ®Google Scholar
• Craig D, Barker S, Banning D, et al. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharma. 1995;114:103–110.
   Web of Science ®Google Scholar
• Patel DP, Li P, Serajuddin AT. Enhanced microemulsion formation in lipid-based drug delivery systems by combining mono-esters of mediumchain fatty acids with di-or tri-esters. J Excipients Food Chem. 2016;3:29–44.
   Google Scholar
• Prajapati HN, Dalrymple DM, Serajuddin AT. A comparative evaluation of mono-, di-and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharm Res. 2012;29:285–305.
   PubMed Web of Science ®Google Scholar
• Prajapati HN, Patel DP, Patel NG, et al. Effect of difference in fatty acid chain lengths of medium-chain lipids on lipid-surfactant-water phase diagrams and drug solubility. J Excipients Food Chem. 2011;2:73–88.
   Google Scholar
• Hodes G. Chemical Solution Deposition of Semiconductor Films. Vol. 191. Marcel Dekker New York;2003.
   Google Scholar